SCHEMBL845283

SCHEMBL845283

O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1CN1CCOCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
ALDH3A1 P30838 1/20 0.51
LMNA P02545 2/20 0.48
CHRM2 P08172 1/20 0.43
OPRM1 P35372 1/20 0.43
DDB1 Q16531 1/20 0.43
CRBN Q96SW2 1/20 0.43
IKZF3 Q9UKT9 1/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
HTR1A P08908 1/20 0.40
DRD2 P14416 1/20 0.40
HTR6 P50406 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3589258 0.82 KMT2A (0.43) ALDH1A1LMNACHRM2OPRM1DDB1
Hydrochloric Acid SCHEMBL3593448 0.82 KMT2A (0.43) ALDH1A1LMNAMAPK1L3MBTL1SMN1; SMN2
SCHEMBL4103132 0.78 DDB1 (0.50) ALDH1A1CHRM2OPRM1DDB1CRBN
SCHEMBL2919642 0.78 CRBN (0.50) ALDH1A1CHRM2OPRM1DDB1CRBN
SCHEMBL3366426 0.77 ALDH1A1 (0.56) ALDH1A1CA1CA2ALDH3A1LMNA
SCHEMBL26489650 0.77 ALDH1A1 (0.69) ALDH1A1CA1CA2ALDH3A1LMNA
SCHEMBL4929916 0.76 CRBN (0.48) ALDH1A1CHRM2OPRM1DDB1CRBN
SCHEMBL4120260 0.76 ALDH1A1 (0.50) ALDH1A1ALDH3A1CHRM2OPRM1DDB1
SCHEMBL24921833 0.75 ALDH1A1 (0.38) ALDH1A1CHRM2OPRM1DDB1CRBN
SCHEMBL4119644 0.74 CASP3 (0.49) ALDH1A1CA2LMNACHRM2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3915556-A1 RECTAL APPLICATION OF THALIDOMIDE IN PATIENTS WITH HEMORRHAGIC CHRONIC RADIATION PROCTITIS Vonnahme, Franz Josef (DE) 2021-12-01 EP disclosed
US-8143283-B1 Methods for treating blood-born tumors with thalidomide THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2012-03-27 US disclosed
US-7723361-B2 Methods for inhibiting undesired angiogenesis in patients having tumors with thalidomide CELGENE CORPORATION (US) 2010-05-25 US disclosed